Bisrat G. Debeb

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center

Affiliated withThe University of Texas MD Anderson Cancer Center

Research Area

Biography

Bisrat G. Debeb has not added Biography.
If you are Bisrat G. Debeb and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2021

Other Publications

Article	Year
Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. International journal of radiation oncology, biology, physics\| PubMed ID: 20159363	2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular cancer\| PubMed ID: 20615238	2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PloS one\| PubMed ID: 20808935	2010
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast cancer research and treatment\| PubMed ID: 22547109	2012
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem cells (Dayton, Ohio)\| PubMed ID: 22961641	2012
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer research\| PubMed ID: 23955388	2013
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PloS one\| PubMed ID: 24013655	2013
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PloS one\| PubMed ID: 24416156	2014
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastec... Stem cells translational medicine\| PubMed ID: 24833589	2014
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. Journal of experimental & clinical cancer research : CR\| PubMed ID: 25051981	2014
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nature cell biology\| PubMed ID: 25086746	2014
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nature communications\| PubMed ID: 25476932	2014
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast cancer research : BCR\| PubMed ID: 25887413	2015
Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 26482599	2015
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast cancer research and treatment\| PubMed ID: 26590814	2015
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 26916073	2016
MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. International journal of radiation oncology, biology, physics\| PubMed ID: 27055396	2016
miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. Journal of the National Cancer Institute\| PubMed ID: 27075851	2016
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget\| PubMed ID: 27078845	2016
Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response. International journal of radiation oncology, biology, physics\| PubMed ID: 27511855	2016
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget\| PubMed ID: 27756885	2016
Inflammatory breast cancer: a model for investigating cluster-based dissemination. NPJ breast cancer\| PubMed ID: 28649661	2017
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. Journal of Cancer\| PubMed ID: 28819368	2017
Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer\| PubMed ID: 29579338	2018
Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer. PloS one\| PubMed ID: 29617367	2018
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference. Journal of Cancer\| PubMed ID: 29667990	2017
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Human pathology\| PubMed ID: 29689244	2018
Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast cancer research and treatment\| PubMed ID: 29858753	2018
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Molecular oncology\| PubMed ID: 31854063	2020
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific reports\| PubMed ID: 32444778	2020
NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers\| PubMed ID: 33321961	2020
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis. Acta neuropathologica\| PubMed ID: 33394124	2021
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Communications biology\| PubMed ID: 33452400	2021